|
Evaluation of the Bioavailability of Pramlintide Clinical Trials Information presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, trips or treatment by using a genuine doctor. We aren't doctors. Always consult your mD on Evaluation of the Bioavailability of Pramlintide conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Evaluation of the Bioavailability of Pramlintide Clinical research trials and Evaluation of the Bioavailability of Pramlintide health trials take place in a lot of of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / projects is to answer specific human medical questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, like Evaluation of the Bioavailability of Pramlintide. Evaluation of the Bioavailability of Pramlintide Clinical Trials and other clinical trials allow for volunteers to have health treatment alternatives before they are available to the general public. Many times the test subjects obtain treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Evaluation of the Bioavailability of Pramlintide clinical trial. Subjects oftentimes recieve the most effective healthcare possible for their Evaluation of the Bioavailability of Pramlintide condition. Hazards are a reality, however, and could include additional or frequent doctor visits, healthcare dangers (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation of the Bioavailability of Pramlintide  Evaluation of the Bioavailability of Pramlintide
Evaluation of the Bioavailability of Pramlintide
For Condition: Diabetes Mellitus, Type 1,Diabetes Mellitus, Type 2
Status: No longer recruiting
Sponsor(s): Amylin Pharmaceuticals ,
Synopsis: This is a randomized, open-label, crossover study to examine the bioavailability of pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes mellitus using insulin.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Open Label, Placebo Control, Crossover Assignment, Bio-availability Study
Minimum Age/Maximum Age: 18 Years/70 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - HbA1c value between 6-12% - BMI <= 27 kg/m2 or BMI >=30 to <= 45 kg/m2 - Consistent insulin regimen for 2 months prior to screening
Total Enrollment:
Location and Contact Information:
DaVita Clinical Research
Minneapolis, Minnesota,
United States
CEDRA Clinical Research, LLC
Austin, Texas,
United States
Orlando Clinical Research Center
Orlando, Florida,
United States
New Orleans Center for Clinical Research
New Orleans, Louisiana,
United States
Additional Information:
Study ID Numbers: 137-153;
Study Start Date: June 2002
Record last reviewed: January 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00042471
Other Diabetes Mellitus, Type 1 Studies:
1. Islet Transplantation for patients with Type 1 diabetes
2. Evaluation of the Effect of Pramlintide on Satiety and Food Intake
3. Matrix metalloproteinases and Diabetic Nephropathy
4. Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients
5. Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control
Related Studies:
Other Diabetes Mellitus, Type 1 Clinical Trials
Other Texas Clinical Trials
Other Austin Clinical Trials
Evaluation of the Bioavailability of Pramlintide
|
|
|
|
|
|
|
|
